These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21135112)

  • 1. Invasive prostate carcinoma driven by c-Src and androgen receptor synergy.
    Cai H; Babic I; Wei X; Huang J; Witte ON
    Cancer Res; 2011 Feb; 71(3):862-72. PubMed ID: 21135112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
    Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
    Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice.
    Kim S; Yang X; Li Q; Wu M; Costyn L; Beharry Z; Bartlett MG; Cai H
    J Biol Chem; 2017 Nov; 292(45):18422-18433. PubMed ID: 28939770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
    Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP
    Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
    Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
    Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.
    Yang JC; Ok JH; Busby JE; Borowsky AD; Kung HJ; Evans CP
    Cancer Res; 2009 Jan; 69(1):151-60. PubMed ID: 19117998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src signaling pathways in prostate cancer.
    Varkaris A; Katsiampoura AD; Araujo JC; Gallick GE; Corn PG
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):595-606. PubMed ID: 24522479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
    Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R
    Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src controls castration recurrence of CWR22 prostate cancer xenografts.
    Su B; Gillard B; Gao L; Eng KH; Gelman IH
    Cancer Med; 2013 Dec; 2(6):784-92. PubMed ID: 24403252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
    Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
    Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.
    Asim M; Siddiqui IA; Hafeez BB; Baniahmad A; Mukhtar H
    Oncogene; 2008 Jun; 27(25):3596-604. PubMed ID: 18223692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.
    Konig H; Copland M; Chu S; Jove R; Holyoake TL; Bhatia R
    Cancer Res; 2008 Dec; 68(23):9624-33. PubMed ID: 19047139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
    Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
    Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.
    Goc A; Al-Husein B; Katsanevas K; Steinbach A; Lou U; Sabbineni H; DeRemer DL; Somanath PR
    Oncotarget; 2014 Feb; 5(3):775-87. PubMed ID: 24519956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
    Lee LF; Guan J; Qiu Y; Kung HJ
    Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Src in prostate cancer.
    Fizazi K
    Ann Oncol; 2007 Nov; 18(11):1765-73. PubMed ID: 17426060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.
    Dai B; Chen H; Guo S; Yang X; Linn DE; Sun F; Li W; Guo Z; Xu K; Kim O; Kong X; Melamed J; Qiu S; Chen H; Qiu Y
    Cancer Res; 2010 Jul; 70(13):5587-96. PubMed ID: 20570899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.